Stockscreener 앱 받기
0.5352
68.35%
0.2173
시간 외 거래:
.52
-0.0152
-2.84%
전일 마감가:
$0.3179
열려 있는:
$0.31
하루 거래량:
60.63M
Relative Volume:
7.38
시가총액:
$23.28M
수익:
순이익/손실:
$-13.25M
주가수익비율:
-1.5149
EPS:
-0.3533
순현금흐름:
$-8.02M
1주 성능:
+28.19%
1개월 성능:
-12.41%
6개월 성능:
-69.06%
1년 성능:
-68.33%
1일 변동 폭
$0.302
$0.85
1주일 범위
$0.295
$0.85
52주 변동 폭
$0.295
$3.15
Estrella Immunopharma Inc Stock (ESLA) Company Profile
명칭
Estrella Immunopharma Inc
전화
(510) 318-9098
주소
5858 HORTON STREET, SUITE 370, EMERYVILLE
Compare ESLA vs VRTX, MRNA, REGN, ARGX, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ESLA
Estrella Immunopharma Inc
|
0.5352 | 23.28M | 0 | -13.25M | -8.02M | -0.3533 |
VRTX
Vertex Pharmaceuticals Inc
|
508.75 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.34 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.27 | 53.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.08 | 42.32B | 5.76B | 514.49M | 1.10B | 4.4813 |
Estrella Immunopharma Inc 주식(ESLA)의 최신 뉴스
Estrella Immunopharma Warrant (ESLAW) Trades Flat at $0.07 as Range Holds TightChaikin Flow - dars.gov.et
Estrella Immunopharma Warrant (ESLAW) Trades Flat at $0.07 as Range Holds TightAI Trade Signals - dars.gov.et
Estrella Immunopharma Warrant (ESLAW) Trades Flat at $0.07 as Range Holds TightHigh Dividend Factor - dars.gov.et
Estrella Immunopharma Faces Nasdaq Listing Compliance Challenge - TipRanks
Estrella Immunopharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Estrella Immunopharma Receives Nasdaq Minimum Bid Price Notice - TipRanks
Estrella Immunopharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
ARMISTICE CAPITAL, LLC Reduces Stake in Estrella Immunopharma Inc (ESLA) by Nearly Half - GuruFocus
Estrella Immunopharma (ESLA) Holds Ground at $0.72 as Immunotherapy Pipeline Takes Center StageLong Short Pair - vinanet.vn
Price to earnings forward of Estrella Immunopharma, Inc. – NASDAQ:ESLA - TradingView
Estrella Immunopharma (ESLA) Holds Ground at $0.72 as Immunotherapy Pipeline Takes Center StageLow Risk Entry Stocks - dars.gov.et
Estrella Immunopharma (ESLA) Holds at $0.72 as Support Firms in Quiet Micro-Cap SessionIchimoku TK Cross - vinanet.vn
ESLAW Warrants Hold Flat at $0.07 as Support and Resistance AlignInstitutional Buy Signals - vinanet.vn
ESLAW Warrants Hold Flat at $0.07 as Support and Resistance AlignTriangle Correction - siam.in
ESLAW Warrants Hold Flat at $0.07 as Support and Resistance AlignScalping Stock Signals - dars.gov.et
Estrella Immunopharma (ESLA) Holds at $0.72 as Support Firms in Quiet Micro-Cap SessionFactor Rotation - dars.gov.et
Estrella Immunopharma Inc. (NASDAQ: ESLA) Share Price, ESLA Stock News, ESLA Share Price & Updates - kalkine.com.au
ESLAW Warrant Holds at $0.07 as Estrella Immunopharma Trades FlatSystematic Flow - vinanet.vn
Estrella Immunopharma (ESLA): Armistice Capital discloses 4.99% ownership stake - Stock Titan
ESLAW Warrant Holds at $0.07 as Estrella Immunopharma Trades FlatPost-Earnings Moves - dars.gov.et
ESLAW Warrant Holds at $0.07 as Estrella Immunopharma Trades FlatFibonacci Fan - dars.gov.et
ESLAW Warrant Holds at $0.07 as Estrella Immunopharma Trades FlatSingle Stock ETF - dars.gov.et
ESLAW Warrant Holds at $0.07 as Estrella Immunopharma Trades FlatLow Risk Entry Stocks - dars.gov.et
Estrella Immunopharma, Inc. 2Q 2026: Net loss $(2.31M), EPS $(0.05) — 10-Q Summary - TradingView
Tranche Update on Estrella Immunopharma, Inc.'s Equity Buyback Plan announced on January 30, 2024. - marketscreener.com
Estrella Immunopharma Activates University Hospitals Cleveland Medical Center as Fourth Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma - BioSpace
Estrella adds fourth site to EB103 lymphoma trial - Investing.com
Estrella Immunopharma Activates University Hospitals Cleveland Medical Center as Fourth Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma - Yahoo Finance
Estrella Immunopharma Inc (ESLA) Stock News Today - TradingKey
Estrella Immunopharma (ESLA) Stock Price, News & Analysis - MarketBeat
Estrella Immunopharma Inc (ESLA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Estrella Immunopharma (ESLA) Rallies 6.11% as CAR T-Cell Focus Draws Investor AttentionEarnings Sentiment - vinanet.vn
Price to book forward of Estrella Immunopharma, Inc. – NASDAQ:ESLAW - tradingview.com
Estrella adds third site to EB103 lymphoma trial - Investing.com
Estrella adds third site to EB103 lymphoma trial By Investing.com - Investing.com South Africa
Estrella Immunopharma Activates Oregon Health & Science University as Third Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma - Business Wire
Estrella Immunopharma (ESLA) Holds at $0.71 as Downside Pressures Remain ContainedTRIN Signal - dars.gov.et
Price to sales forward of Estrella Immunopharma, Inc. – BOATS:ESLAW - TradingView
Price to book forward of Estrella Immunopharma, Inc. – NASDAQ:ESLA - TradingView
Estrella Immunopharma (ESLA) Holds at $0.71 as Downside Pressures Remain ContainedTrend Following Picks - vinanet.vn
Estrella activates second site for EB103 lymphoma trial By Investing.com - Investing.com Canada
Estrella Immunopharma Activates Baylor Scott & White Research Institute as Second Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma - Yahoo Finance
Estrella Immunopharma Inc (ESLA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Estrella Immunopharma Inc (ESLA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Estrella Immunopharma Inc (ESLA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Estrella Immunopharma Inc (ESLA) Balance Sheet - TradingKey
Estrella Immunopharma Inc (ESLA) Cash Flow - TradingKey
Estrella Immunopharma Inc (ESLA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
Estrella Immunopharma Inc (ESLA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Estrella Immunopharma Inc 주식 (ESLA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Xu Jiandong | Chief Financial Officer |
Aug 18 '26 |
Option Exercise |
0.81 |
100,000 |
81,500 |
365,488 |
| Xu Jiandong | Chief Financial Officer |
Oct 07 '25 |
Buy |
1.33 |
1,000 |
1,330 |
265,488 |
1.35%
자본화:
|
볼륨(24시간):